We are live on
!
Find out more
BE
Bonness Enterprises Portfolio holdings
AUM
$310M
1-Year Est. Return
24.22%
This Fund
S&P 500
This Quarter
Est. Return
-2.75%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$273M
AUM Growth
-$16.6M
(-5.7%)
Cap. Flow
-$1.93M
Cap. Flow
% of AUM
-0.71%
Top 10 Holdings %
Top 10 Hldgs %
73.23%
Holding
39
New
1
Increased
2
Reduced
8
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$426K |
| 2 |
Chevron
CVX
|
+$201K |
| 3 |
HP
HPQ
|
+$9.72K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$2.38M |
| 2 |
Intel
INTC
|
+$45.8K |
| 3 |
MICC
The Magnum Ice Cream Company N.V.
MICC
|
+$38.3K |
| 4 |
Stryker
SYK
|
+$35.9K |
| 5 |
Johnson & Johnson
JNJ
|
+$23.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 40.46% |
| 2 | Healthcare | 25.44% |
| 3 | Technology | 24.51% |
| 4 | Industrials | 3.35% |
| 5 | Communication Services | 1.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$128B
| $102M | 37.19% |
512,457
| – | – |
|
|
2
Stryker
SYK
$134B
| $21M | 7.68% |
63,839
-100
| -0.2% | -$35.9K |
|
3
Microsoft
MSFT
$2.95T
| $14.2M | 5.22% |
38,490
-50
| -0.1% | -$20.9K |
|
4
Apple
AAPL
$5.05T
| $12.5M | 4.56% |
49,070
| – | – |
|
|
5
Johnson & Johnson
JNJ
$641B
| $9.42M | 3.45% |
38,538
-100
| -0.3% | -$23.3K |
|
|
6
Corning
GLW
$108B
| $9.06M | 3.31% |
66,600
-19,700
| -23% | -$2.38M |
|
7
Applied Materials
AMAT
$362B
| $8.47M | 3.1% |
24,776
| – | – |
|
8
Merck
MRK
$323B
| $8.36M | 3.06% |
69,500
| – | – |
|
9
AbbVie
ABBV
$470B
| $8.03M | 2.94% |
36,900
| – | – |
|
10
Cisco
CSCO
$452B
| $7.45M | 2.73% |
96,000
-100
| -0.1% | -$7.83K |
|
11
IBM
IBM
$216B
| $7.17M | 2.62% |
29,564
| – | – |
|
12
Emerson Electric
EMR
$82.9B
| $5.63M | 2.06% |
43,000
| – | – |
|
|
13
Pfizer
PFE
$143B
| $4.98M | 1.82% |
177,508
+16,000
| +10% | +$426K |
|
14
Nucor
NUE
$58.5B
| $4.59M | 1.68% |
27,135
-100
| -0.4% | -$17.4K |
|
|
MRSH
15
Marsh
MRSH
$94B
| $4.39M | 1.61% |
25,300
| – | – |
|
16
Thermo Fisher Scientific
TMO
$213B
| $4.36M | 1.6% |
8,875
| – | – |
|
|
17
Intel
INTC
$431B
| $4.27M | 1.56% |
96,850
-1,000
| -1% | -$45.8K |
|
18
Abbott
ABT
$189B
| $3.36M | 1.23% |
32,700
| – | – |
|
19
Bristol-Myers Squibb
BMY
$130B
| $3.29M | 1.21% |
54,300
| – | – |
|
20
AT&T
T
$167B
| $2.59M | 0.95% |
89,200
| – | – |
|
21
Verizon
VZ
$201B
| $2.53M | 0.93% |
50,431
| – | – |
|
22
ExxonMobil
XOM
$647B
| $2.41M | 0.88% |
14,185
| – | – |
|
23
Philips
PHG
$25.5B
| $2.38M | 0.87% |
90,190
| – | – |
|
24
Procter & Gamble
PG
$338B
| $2.37M | 0.87% |
16,400
| – | – |
|
25
GSK
GSK
$106B
| $2.29M | 0.84% |
41,480
| – | – |
|
Similar funds
IPW
TL
RGC
IR
TWM
PH
CCG
OPTFSNA
Bonness Enterprises's Q1 2026 Portfolio in Review
As of Q1 2026, Bonness Enterprises held 39 positions worth $273M, down 5.7% from $290M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 2.6%. Bonness Enterprises opened 1 new position and made no exits, leaving the 39-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 44% a quarter earlier, followed by Healthcare and Technology.
- Bonness Enterprises's largest Q1 2026 buy was Chevron: 1,100 shares worth $228K.
- Bonness Enterprises added most to Pfizer in Q1 2026, an estimated $426K increase.
- Bonness Enterprises's biggest Q1 2026 reduction was Corning, cutting an estimated $2.38M.
- Bonness Enterprises's ten largest holdings make up 73% of its $273M portfolio in Q1 2026.
- Bonness Enterprises opened 1 new position and closed 0 in Q1 2026.
- Bonness Enterprises's portfolio value fell 5.7% quarter-over-quarter to $273M.
Based on Bonness Enterprises's 13F filing for Q1 2026, filed 15 Apr 2026.